BIS Research Report Highlights the Global Precision Medicine Market to Reach $278.61 Billion by 2030
FREMONT, Calif., Sept. 17, 2020 /PRNewswire/ -- The global precision medicine market is projected to reach $278.61 billion by 2030, reveals a premium market intelligence report by BIS Research. The study also highlights that the market is set to witness a CAGR of 11.13% during the period between 2020 and 2030.
The comprehensive study of the global precision medicine market by BIS Research extensively covers the following:
• Market numbers on micro-segments that are influencing the market
• More than 1500 products present in the market
• Pricing data for more than 500 products
• Market share analysis for more than 20 product categories
• Detailed global and regional market share analysis including the scrutiny of more than 15 countries
• Study of data of more than 60 companies
The detailed report is a compilation of 19 Market Data Tables and 330 Figures spread through 529 Pages and in-depth TOC on "Global Precision Medicine Market"
Besides these parameters, the report also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segmental analysis, and a visual dashboard of 1400+ products.
The BIS Research report indicates that the increasing number of genetic tests taken, the growing demand for reliable next-generation sequencing (NGS) results, the rising prevalence of infectious diseases, and the improving funding scenario in the field of precision medicine, among others, are fueling the growth of the market.
It also highlights the various emerging opportunities, such as growth in emerging nations, capitalization on the high prevalence of cancer, and the evolution of technology in healthcare, that can be leveraged ...
More on: www.prnewswire.co.uk